SCHEMBL6575670

SCHEMBL6575670

CCCCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(CNC(=O)O)CC(C)C

nearest known ligand 0.84

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 15/20 0.84
MMP2 P08253 7/20 0.84
MMP8 P22894 6/20 0.84
MMP7 P09237 2/20 0.79
MMP9 P14780 3/20 0.77
MMP3 P08254 1/20 0.63
ECE1 P42892 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6438804 0.89 MMP1 (0.67) MMP1MMP2MMP8MMP7MMP9
SCHEMBL7408047 0.88 MMP1 (1.00) MMP1MMP2MMP8MMP7MMP9
SCHEMBL6431245 0.88 MMP8 (0.75) MMP1MMP2MMP8MMP7MMP9
SCHEMBL17941642 0.87 MMP2 (0.74) MMP1MMP2MMP8MMP7MMP9
SCHEMBL17941644 0.87 MMP2 (0.74) MMP1MMP2MMP8MMP7MMP9
SCHEMBL6577614 0.86 MMP2 (0.80) MMP1MMP2MMP8MMP7MMP9
SCHEMBL7765890 0.86 MMP2 (0.80) MMP1MMP2MMP8MMP7MMP9
SCHEMBL6439250 0.86 MMP2 (0.80) MMP1MMP2MMP8MMP7MMP9
SCHEMBL6431194 0.86 ECE1 (0.79) MMP1MMP2MMP8MMP7MMP9
SCHEMBL19728220 0.85 MMP8 (0.74) MMP1MMP2MMP8MMP7MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0558648-B1 IMPROVED MATRIX METALLOPROTEASE INHIBITORS GALARDY RICHARD E (US) 2004-04-28 EP disclosed
EP-0663823-B1 INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS GLYCOMED INC (US) 2000-11-22 EP disclosed
EP-0558681-B1 TREATMENT FOR TISSUE ULCERATION UNIV FLORIDA (US) 1998-04-08 EP disclosed
EP-0558635-B1 IMPROVED MATRIX METALLOPROTEASE INHIBITORS GLYCOMED INC (US) 1997-09-10 EP disclosed
EP-0663823-A4 INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS. GLYCOMED INC (US) 1997-06-04 EP disclosed
EP-0663823-A1 INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS GLYCOMED INCORPORATED (US) 1995-07-26 EP disclosed
WO-1994022309-A1 SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF GLYCOMED INCORPORATED (US) 1994-10-13 WO disclosed
US-5268384-A Containing amide groups GLYCOMED, INC., A CA CORP 1993-12-07 US disclosed
EP-0558635-A4 IMPROVED MATRIX METALLOPROTEASE INHIBITORS 1993-11-24 EP disclosed
EP-0558648-A4 IMPROVED MATRIX METALLOPROTEASE INHIBITORS 1993-11-24 EP disclosed
EP-0558635-A1 IMPROVED MATRIX METALLOPROTEASE INHIBITORS. GLYCOMED INC (US) 1993-09-08 EP disclosed
EP-0558648-A1 IMPROVED MATRIX METALLOPROTEASE INHIBITORS GALARDY, Richard, E. (US) 1993-09-08 EP disclosed
US-5239078-A Collagenase enzyme inhibitors GLYCOMED INCORPORATED (US) 1993-08-24 US disclosed
WO-1993013741-A2 INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS GLYCOMED, INC. (US) 1993-07-22 WO disclosed
US-5189178-A Preventing protein destruction GALARDY RICHARD E (US) 1993-02-23 US disclosed
US-5183900-A Matrix metalloprotease inhibitors GALARDY RICHARD E (US) 1993-02-02 US disclosed
WO-1992009556-A1 IMPROVED MATRIX METALLOPROTEASE INHIBITORS GALARDY RICHARD E (US) 1992-06-11 WO disclosed
WO-1992009563-A1 IMPROVED MATRIX METALLOPROTEASE INHIBITORS GLYCOMED, INC. (US) 1992-06-11 WO disclosed